Document is current
Any future updates will be listed below
-
Authors
Ciudin, Andreea https://orcid.org/0000-0001-5622-0203
Johansson, Erin
Zimner-Rapuch, Sarah
Dimitriadis, Georgios K. https://orcid.org/0000-0002-6662-804X
Bertrand, Marine https://orcid.org/0000-0001-8139-7924
Curteis, Tristan
Clark, Laura J. https://orcid.org/0000-0003-4378-2420
Fan, Ludi
Sapin, Helene
Bergmann, Jean-Francois
- License Information
-
More Information
Article History
Received: 14 August 2025
Revised: 29 July 2026
Accepted: 7 September 2026
First Online: 28 September 2026
Ethics
Competing interests: AC: Honoraria from AstraZeneca, Boehringer Ingelheim, Lilly, Novo Nordisk; Member of the DMC of Boehringer Ingelheim clinical trials-SYNCRONIZE program; EJ, SZR, GKD, MB, LF, HS: Employee and shareholder of Eli Lilly and Company; TC, LJC: Employees of Costello Medical, which received payment from Eli Lilly and Company for analytical services for this study; JFB: Received honoraria from Abbvie, Amgen, Astellas, AstraZeneca, Bayer, BeiGene, Gilead, GSK, IQVIA, Janssen, Lilly, Novartis, Pfizer, Roche, Sanofi, Takeda.
Ethical approval: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
